Status:
COMPLETED
Q-Switched Nd:YAG in Macular Amyloidosis
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
Macular Amyloidosis
Eligibility:
All Genders
18-70 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine whether Q-Switched Nd:YAG Laser therapy are effective in reduction of Cutaneous macular amyloidosis.
Detailed Description
We treat the macular amyloidosis cases by Q-Switched Nd:YAG Laser and compare the before and after treatment situation by the photos and colorimetric assessment.
Eligibility Criteria
Inclusion
- Macular amyloidosis confirmed cases
Exclusion
- Pregnancy and breast feeding
- Over 18 years old
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
End Date :
August 1 2006
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00353392
Start Date
March 1 2006
End Date
August 1 2006
Last Update
December 19 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Skin Research Center, Shaheed Beheshti Medical University
Tehran, Iran, 19899